INSIDER · CIK 2119332
Kemula Pierre Thadee Victor
Chief Financial Officer at AgomAb Therapeutics NV (AGMB)
↗1 Form 4 rows in the window
Covers original filings from Jul 31, 2026 to Oct 28, 2026. Older trades and amendments are in the SEC history.
$86KBought on the market
$0.00Sold on the market
1Companies
Oct 7, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 7, 202608:47 | Oct 6, 2026 | AGMBAgomAb Therapeutics NV | Chief Financial Officer | P · Buy | $8.59 | +10,000 | 10,000 | New | +$86K | -45.5% | -7.4% |